InsidersTradesSigma
화일약품: insider trades · South Korea · DART (FSS)
DART:company-be7e52KR·DART (FSS)Mcap 96.2Bn€Healthcare
Discover the full directors' dealings record of 화일약품, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 화일약품 has recorded 13 reports. Market capitalisation: €96.2bn. The latest transaction was filed on 16 April 2026 — Sale. Among the most active insiders: 오성첨단소재. The full history is accessible without an account.
13
Insider Decl.
0
Thresholds
€2,733
2 ops.
Buy Volume
€159m
10 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
8180.00 €
Analyst consensus
Income statement
Revenue100.82 Bn€
Gross profit6.64 Bn€7% margin
Net income−233.0 M€1.8% margin
Valuation
Beta0.28
Balance sheet & cash
Market cap96.21 Bn€
Total debt335.3 M€
Free Cash Flow7.88 Bn€
Debt / Equity16%
Profitability & ownership
ROE1.9%
ROA1.1%
% insiders44.7%
% institutions0.3%
Last declaration on 16 April 2026
Declarations13 total
Executives●Other0DART
DART:20260309001527·details not loaded
13 of 13 declarations